TWAPF (OTC) is a cross-listing of 4553.T (JPX). Showing primary listing data.
4553.T
Towa Pharmaceutical Co., Ltd.
1W: +1.2%
1M: -9.2%
3M: +35.7%
YTD: +6.7%
1Y: +41.6%
3Y: +112.8%
5Y: +135.7%
¥4,175.00 ($26.16)
+15.00 (+0.36%)
Weekly Expected Move ±6.0%
¥3670
¥3920
¥4170
¥4420
¥4670
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥205.5B ($1.3B)
52W Range2298-4445
Volume73,700
Avg Volume115,522
Beta-0.30
Dividend¥71.87
Analyst Ratings
No analyst coverage
Company Info
CEOItsuro Yoshida
Employees4,588
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2004-04-05
Websitetowayakuhin.co.jp
2-11, Shinbashi-cho
Osaka 571-8580
JP
Osaka 571-8580
JP
81 6 6900 9100
About Towa Pharmaceutical Co., Ltd.
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.
Latest News
No recent news
Recent Insider Trades
No insider trades found